Toggle light / dark theme

New neurons may reverse damage in Huntington’s disease

New research shows that the adult brain can generate new neurons that integrate into key motor circuits. The findings demonstrate that stimulating natural brain processes may help repair damaged neural networks in Huntington’s and other diseases.

“Our research shows that we can encourage the brain’s own cells to grow new neurons that join in naturally with the circuits controlling movement,” said a senior author of the study, which appears in the journal Cell Reports. “This discovery offers a potential new way to restore brain function and slow the progression of these diseases.”

It was long believed that the adult brain could not generate new neurons. However, it is now understood that niches in the brain contain reservoirs of progenitor cells capable of producing new neurons. While these cells actively produce neurons during early development, they switch to producing support cells called glia shortly after birth. One of the areas of the brain where these cells congregate is the ventricular zone, which is adjacent to the striatum, a region of the brain devastated by Huntington’s disease.

The Rise of Cyborgs: Merging Man with Machine | Terrifying Future of Human Augmentation

Human cyborgs are individuals who integrate advanced technology into their bodies, enhancing their physical or cognitive abilities. This fusion of man and machine blurs the line between science fiction and reality, raising questions about the future of humanity, ethics, and the limits of human potential. From bionic limbs to brain-computer interfaces, cyborg technology is rapidly evolving, pushing us closer to a world where humans and machines become one.

Shocking transformation, futuristic nightmare, beyond human limits, man merges with machine, terrifying reality, future is now, ultimate evolution, secret experiments exposed, technology gone too far, sci-fi turns real, mind-blowing upgrade, science fiction no more, unstoppable machine man, breaking human boundaries, dark future ahead, human cyborgs, cyborg technology, cyborg implants, cyborg augmentation, cyborg evolution, cyborg future, cyborg innovations, cyborg advancements, cyborg ethics, cyborg integration, cyborg society, cyborg culture, cyborg development, cyborg research, cyborg science, cyborg engineering, cyborg design, cyborg applications, cyborg trends, cyborg news, cyborg updates, cyborg breakthroughs, cyborg discoveries, cyborg implants, bionic limbs, neural interfaces, prosthetic enhancements, biohacking, cybernetics, exoskeletons, brain-computer interfaces, robotic prosthetics, augmented humans, wearable technology, artificial organs, human augmentation, smart prosthetics, neuroprosthetics, biomechatronics, implantable devices, synthetic biology, transhumanism, bioengineering, nanotechnology, genetic engineering, bioinformatics, artificial intelligence, machine learning, robotics, automation, virtual reality, augmented reality, mixed reality, haptic feedback, sensory augmentation, cognitive enhancement, biofeedback, neurofeedback, brain mapping, neural networks, deep learning, biotechnology, regenerative medicine, tissue engineering, stem cells, gene therapy, personalized medicine, precision medicine, biomedical engineering, medical devices, health tech, digital health, telemedicine, eHealth, mHealth, health informatics, wearable sensors, fitness trackers, smartwatches, health monitoring, remote monitoring, patient engagement, health apps, health data, electronic health records, health analytics, health AI, medical robotics, surgical robots, rehabilitation robotics, assistive technology, disability tech, inclusive design, universal design, accessibility, adaptive technology, human-machine interaction, human-computer interaction, user experience, user interface, UX design, UI design, interaction design, design thinking, product design, industrial design, innovation, technology trends, future tech, emerging technologies, disruptive technologies, tech startups, tech entrepreneurship, venture capital, startup ecosystem, tech innovation, research and development, R&D, scientific research, science and technology, STEM, engineering, applied sciences, interdisciplinary research, academic research, scholarly articles, peer-reviewed journals, conferences, symposiums, workshops, seminars, webinars, online courses, e-learning, MOOCs, professional development, continuing education, certifications, credentials, skills development, career advancement, job market, employment trends, workforce development, labor market, gig economy, freelancing, remote work, telecommuting, digital nomads, coworking spaces, collaboration tools, project management, productivity tools, time management, work-life balance, mental health, wellness, self-care, mindfulness, meditation, stress management, resilience, personal growth, self-improvement, life coaching, goal setting, motivation, inspiration, success stories, case studies, testimonials, reviews, ratings, recommendations, referrals, networking, professional associations, industry groups, online communities, forums, discussion boards, social media, content creation, blogging, vlogging, podcasting, video production, photography, graphic design, animation, illustration, creative arts, performing arts, visual arts, music, literature, film, television, entertainment, media, journalism, news, reporting, storytelling, narrative, communication, public speaking, presentations, persuasion, negotiation, leadership, management, entrepreneurship, business, marketing, advertising, branding, public relations, sales, customer service, client relations, customer experience, market research, consumer behavior, demographics, psychographics, target audience, niche markets, segmentation, positioning, differentiation, competitive analysis, SWOT analysis, strategic planning, business development, growth strategies, scalability, sustainability, corporate social responsibility, ethics, compliance, governance, risk management, crisis management, change management, organizational behavior, corporate culture, diversity and inclusion, team building, collaboration, innovation management, knowledge management, intellectual property, patents, trademarks, copyrights.

Getting treatment for high blood pressure may reduce chances of developing dementia

Reducing high blood pressure substantially lowers the risk of dementia and cognitive impairment without dementia, according to the results of a phase 3 clinical trial involving almost 34,000 patients, published in Nature Medicine. These findings highlight the potential importance of widespread adoption of more intensive blood pressure control among patients with hypertension to reduce the global disease burden of dementia.

It is estimated that the global number of people with dementia will rise from 57.4 million in 2019 to 152.8 million by 2050, with the greatest impact being in low-to middle-income countries. Previous research suggests that , such as eating a healthy diet and exercising regularly, could be the most effective way to reduce the growing global incidence of dementia.

Research has also found that people with untreated hypertension have a 42% greater risk of developing dementia in their lifetime than healthy study participants. However, only a few randomized controlled trials have tested the effect of medications that reduce blood pressure on the risk of dementia, and none have looked at it as a primary trial endpoint.

Wearable device tracks individual cells in the bloodstream in real time

Researchers at MIT have developed a noninvasive medical monitoring device powerful enough to detect single cells within blood vessels, yet small enough to wear like a wristwatch. One important aspect of this wearable device is that it can enable continuous monitoring of circulating cells in the human body. The technology was reported in npj Biosensing.

The device—named CircTrek—was developed by researchers in the Nano-Cybernetic Biotrek research group, led by Deblina Sarkar, assistant professor at MIT and AT&T Career Development Chair at the MIT Media Lab. This technology could greatly facilitate early diagnosis of disease, detection of disease relapse, assessment of infection risk, and determination of whether a disease treatment is working, among other medical processes.

Whereas traditional blood tests are like a snapshot of a patient’s condition, CircTrek was designed to present real-time assessment, referred to in the npj Biosensing paper as having been “an unmet goal to date.” A different technology that offers monitoring of cells in the bloodstream with some continuity, in vivo flow cytometry, “requires a room-sized microscope, and patients need to be there for a long time,” says Kyuho Jang, a Ph.D. student in Sarkar’s lab.

AI model analyzes brain scans to predict relapse risk in pediatric brain cancer

Artificial intelligence (AI) shows tremendous promise for analyzing vast medical imaging datasets and identifying patterns that may be missed by human observers. AI-assisted interpretation of brain scans may help improve care for children with brain tumors called gliomas, which are typically treatable but vary in risk of recurrence.

Investigators from Mass General Brigham and collaborators at Boston Children’s Hospital and Dana-Farber/Boston Children’s Cancer and Blood Disorders Center trained deep learning algorithms to analyze sequential, post-treatment brain scans and flag patients at risk of cancer recurrence.

Their results are published in NEJM AI.

Scientists discover how to reactivate cancer’s molecular ‘kill switch’

Alternative RNA splicing is like a movie editor cutting and rearranging scenes from the same footage to create different versions of a film. By selecting which scenes to keep and which to leave out, the editor can produce a drama, a comedy, or even a thriller—all from the same raw material. Similarly, cells splice RNA in different ways to produce a variety of proteins from a single gene, fine-tuning their function based on need. However, when cancer rewrites the script, this process goes awry, fueling tumor growth and survival.

In a recent study reported in the Feb. 15 issue of Nature Communications, scientists from The Jackson Laboratory (JAX) and UConn Health not only show how cancer hijacks this tightly regulated splicing and rearranging of RNA but also introduce a potential therapeutic strategy that could slow or even shrink aggressive and hard-to-treat tumors. This discovery could transform how we treat aggressive cancers, such as and certain , where current treatment options are limited.

At the heart of this work, led by Olga Anczuków, an associate professor at JAX and co-program leader at the NCI-designated JAX Cancer Center, are tiny genetic elements called poison exons, nature’s own “off switch” for protein production. When these exons are included in an RNA message, they trigger its destruction before a protein can be made—preventing harmful cellular activity. In , poison exons regulate the levels of key proteins, keeping the genetic machinery in check. But in cancer, this safety mechanism often fails.